ASP Isotopes, Inc. (ASPI)
NASDAQMaterialsChemicals - SpecialtySnapshot 2026-09-04
$4.20+7.69%
Close 2026-09-04 · 1-day change
NASDAQMaterialsChemicals - SpecialtySnapshot 2026-09-04
QuarterlyIQ Insights · ASPI
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance sits well below its industry cohort — worth keeping an eye on, though it has not freshly broken.
One-year growth currently built into the price, compared with our model's estimate.
A comparable price-assumption read is not available for this company.
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
Usually moved in the same direction.
Price observations: 365 days
Most sensitive to the broad stock market.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Worth watching into the next print: this name has erratic recent earnings surprises and missed its most recent quarter. A fundamental tilt, not a price call.
Model as of 2026-09-04 · Compared with 40 industry peers · Company calendar date is not available
ASPI — credit agreement
Dated 2026-08-20
Entry into a Material Definitive Agreement. On August 14, 2026, Renergen Limited (the “Borrower”), a wholly-owned subsidiary of ASP Isotopes Inc. (the “Company”), entered into a Second Amendment and Restatement Agreement (the “Second Amendment”) with The Standard Bank of South Africa Limited (the “Lender”). Capitalized terms which are not defined herein shall have the meanings ascribed to such terms in the Second Amendment. The Second Amendment replaced the Amended and Restated Secured Term L…
Why it matters: Successful shipments will prove ASP Isotopes can make and deliver enriched isotopes. This is key for growth.
Supportive ifFirst commercial shipments of Silicon-28 and Ytterbium-176 will happen in 2H 2026.
Worry ifCommercial shipments are delayed beyond 2H 2026.
Why it matters: This research is vital for ASPI's role in the domestic nuclear fuel supply chain. It may lead to future contracts.
Watch forResearch shows uranium conversion works better now.
Also watch forResearch shows no major gains in uranium conversion.
Why it matters: Positive revenue growth would signal a change in the declining trend of the materials sector. This could improve investor confidence.
Supportive ifRevenue growth turns positive after being near -1 percent.
Worry ifRevenue growth remains negative or worsens.
Why it matters: Ongoing lawsuits could affect financial health and how investors feel.
Worry ifGood court outcomes can lower potential costs.
Less concerning ifBad court outcomes can raise costs or cause regulatory issues.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$382 on $10,000 · ±3.8% | How much price usually moves either way. |
| Bad day | $1,046 loss on $10,000 · 10.5% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $7,480 loss on $10,000 · 74.8% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: This merger could improve ASP Isotopes' market position. It may also give more resources for growth.
Watch forThe reverse merger is done. This leads to a Nasdaq listing for Noble Africa.
Also watch forThe reverse merger faces significant delays or fails to complete.
Why it matters: Lawsuit results can affect the company's reputation and money. Investors need to know.
Worry ifA good outcome or settlement of the lawsuit can improve the company's outlook.
Less concerning ifA bad ruling or a worse lawsuit can damage the company's reputation.
Why it matters: Hitting this target would show strong growth for ASP Isotopes. It indicates market demand for their products.
Supportive ifRevenue from radiopharmacies in Q3 2026 meets or exceeds $10 million.
Worry ifRevenue from radiopharmacies is below $5 million in Q3 2026.
Why it matters: Meeting this revenue target shows the company can grow and be financially healthy.
Supportive ifPET Labs revenue reaches or exceeds $14 million by the end of 2026.
Worry ifPET Labs revenue falls short of $14 million by the end of 2026.
Why it matters: Starting production is key to generating revenue from helium and LNG. This will show if the company can meet its targets.
Supportive ifHelium and LNG production will start as planned in September 2026.
Worry ifProduction does not start in September 2026 or is delayed a lot.
Why it matters: Plans for Phase 2 construction will indicate growth potential and future revenue streams for the company.
Supportive ifA timeline for starting Phase 2 construction will be announced in 2H 2026.
Worry ifNo updates or delays in announcing Phase 2 construction plans.